The store will not work correctly when cookies are disabled.
5-hydroxy-2-[3-(p-tolyl)propyl]chromen-4-one
ID: ALA4741776
PubChem CID: 162647275
Max Phase: Preclinical
Molecular Formula: C19H18O3
Molecular Weight: 294.35
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(CCCc2cc(=O)c3c(O)cccc3o2)cc1
Standard InChI: InChI=1S/C19H18O3/c1-13-8-10-14(11-9-13)4-2-5-15-12-17(21)19-16(20)6-3-7-18(19)22-15/h3,6-12,20H,2,4-5H2,1H3
Standard InChI Key: GTOWNCYJAZBDEI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
13.2098 -16.8762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2087 -17.6957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9167 -18.1047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9150 -16.4673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6236 -16.8726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6224 -17.6978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3325 -18.1091 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0483 -17.6998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0495 -16.8747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3349 -16.4587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3349 -15.6416 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9125 -15.6502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7549 -18.1104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4637 -17.7038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1703 -18.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8791 -17.7078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5829 -18.1214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2913 -17.7154 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2940 -16.8974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5825 -16.4869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8770 -16.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0023 -16.4898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
4 12 1 0
8 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 294.35 | Molecular Weight (Monoisotopic): 294.1256 | AlogP: 3.98 | #Rotatable Bonds: 4 |
Polar Surface Area: 50.44 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.46 | CX Basic pKa: ┄ | CX LogP: 5.28 | CX LogD: 5.01 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.79 | Np Likeness Score: 0.67 |
References
1. Kim M,Truss M,Pagare PP,Essandoh MA,Zhang Y,Williams DA. (2020) Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT receptor antagonist scaffold., 30 (21.0): [PMID:32853682] [10.1016/j.bmcl.2020.127511] |